Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diosmin is a naturally occurring flavonoid glycoside found mainly in citrus fruits and used as a venoactive drug to support vascular health. It is primarily indicated for the treatment of chronic venous insufficiency (CVI), hemorrhoids, varicose veins, and venous leg ulcers. Diosmin acts as a phlebotonic and vascular protector by improving lymphatic drainage, increasing venous tone and capillary resistance, reducing capillary permeability, and enhancing microcirculation. Its mechanism of action includes inhibition of noradrenaline metabolism in the venous wall—prolonging smooth muscle contraction—and modulation of lymphatic vessel function. Diosmin also exhibits antioxidant, anti-inflammatory, antidiabetic, antihyperlipidemic, antifibrotic, antibacterial properties in various disease models[2][3][5][6]. It is available over-the-counter in many countries (often as micronized purified flavonoid fraction or MPFF) with a favorable safety profile[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diosmin.